Carrier Screening Market Expected to Reach USD 5.91 Billion by 2030, Driven by NGS Adoption and Expanded Panels

Mordor Intelligence has published a new report on carrier screening market offering a comprehensive analysis of trends, growth drivers, and future projection

Introduction

The carrier screening market stood at USD 3.36 billion in 2025 and is forecast to climb to USD 5.91 billion by 2030, registering an 11.95% CAGR over the period, according to the latest analysis by Mordor Intelligence. This impressive projected expansion reflects a compound annual growth rate (CAGR) of around 11.95 percent over the forecast period. Key factors fueling this growth include falling costs of next-generation sequencing (NGS), increasing integration of carrier screening into reproductive healthcare, broader insurance coverage, and consolidation among laboratories.

Report Overview:

https://www.mordorintelligence.com/industry-reports/carrier-screening-market?utm_source=openpr

Key Trends in the Carrier Screening Market

Lower Costs of Sequencing Technology

One of the most significant drivers of the carrier screening market growth is the decline in the cost of next-generation sequencing. As NGS becomes more affordable, testing labs are increasingly shifting from single-gene assays to more comprehensive, multi-gene panels. This cost reduction is making carrier screening accessible to a wider population and encouraging its adoption even in resource-constrained settings.

Integration into Reproductive and Fertility Care

Carrier screening is increasingly being woven into the routine workflows of fertility centers and assisted reproductive technologies (ART). Many IVF clinics now recommend screening prospective parents before conception or during early pregnancy to help guide embryo and gamete selection. Professional guidelines are also expanding: for example, recommended variant panels for certain diseases have broadened, reflecting the deeper integration of carrier testing in reproductive medicine.

Growing Employer and Population-Level Programs

Employer-sponsored genetic benefit programs, pilot population screening initiatives, and greater payer support are all contributing to rising adoption. Some large-scale public-health screening programs are backing carrier screening, which not only raises awareness, but also helps labs scale up. This broader adoption is helping drive up volumes, lowering per-test costs, and supporting sustainable market expansion.

Multi-Gene Panel Uptake

The shift from targeted single-gene tests to expanded multi-gene panels is a clear trend. These broader panels offer better risk detection for diverse populations, and labs are packaging them at competitive pricing. As sequencing costs drop, multi-gene tests are becoming more cost-effective and clinically valuable, contributing strongly to overall market expansion.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:

https://www.mordorintelligence.com/ja/industry-reports/carrier-screening-market?utm_source=openpr

Market Segmentation in the Carrier Screening Market

The carrier screening market analysis by Mordor Intelligence breaks the market into multiple segments, each reflecting a key dimension of how tests are offered and used:

By Test Type

Molecular Screening Tests

Biochemical Screening Tests

By Disease Type

Cystic Fibrosis

Tay-Sachs Disease

Gaucher Disease

Sickle Cell Disease

Spinal Muscular Atrophy

Other Autosomal Recessive Disorders

By Panel Type

Targeted Single-Gene Panels

Ethnicity-Specific Panels

Expanded Multi-Gene Panels

By Technology

Next-Generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)

Microarrays

Others

By End-User

Hospitals & Clinics

Diagnostic Laboratories

Physician Offices & IVF Centers

Academic & Research Institutes

By Geography

North America

Europe

Asia-Pacific

Middle East & Africa

South America

Key Players in the Carrier Screening Market

The carrier screening market is somewhat concentrated, with several large firms playing a major role:

Illumina Inc.

Thermo Fisher Scientific Inc.

Abbott Laboratories

F.Hoffmann-La Roche Ltd

Danaher Corporation (Cepheid)

These companies are competing not only on technology, but also on scale, cost, and ability to provide integrated counseling and interpretation services.

Know more about the major players in the market: https://www.mordorintelligence.com/industry-reports/carrier-screening-market/companies?utm_source=openpr

Conclusion

The carrier screening market is poised for significant expansion in the coming years, supported by declining sequencing costs, integration into reproductive health workflows, and growing multi-gene panel adoption. However, its growth will be influenced by how well the industry addresses challenges such as genetic-counselor shortages and inconsistent reimbursement policies.

As major players continue to scale their operations and expand service offerings, the market is likely to see more consolidation, innovative testing models, and increased access globally. For clinicians, laboratories, and payers, this shift represents an opportunity: by leveraging broader screening panels and more cost-effective technologies, they can support better-informed reproductive decisions and more inclusive preventive care.

For complete market analysis, please visit the Mordor Intelligence page:

https://www.mordorintelligence.com/industry-reports/carrier-screening-market?utm_source=openpr

Industry related Reports:

Gene Panel Market: The Gene Panel Market is segmented by products and services, including test kits, testing services, and other offerings; by technique, covering amplicon-based methods, hybridization capture, and additional approaches; by application, such as cancer risk assessment, pharmacogenetics, and other clinical uses; and by end user, including hospitals and clinics, diagnostic laboratories, and more. The market is also analyzed across major geographic regions-North America, Europe, Asia-Pacific, and others-with forecasts provided in terms of value (USD).

Get more insights: https://www.mordorintelligence.com/industry-reports/gene-panel-market?utm_source=openpr

North America Trace Detection Screening Market: The North American Trace Detection Screening Market Report provides segmentation across multiple dimensions, including type (explosive and narcotics), product categories (handheld, portable/movable, and fixed systems), and end-user industries such as commercial, military and defense, law enforcement, ports and borders, public safety, and other sectors. It also covers country-level analysis for the United States and Canada. The report presents market sizes and forecasts for all these segments in terms of value (USD).

Get more insights: https://www.mordorintelligence.com/industry-reports/north-america-trace-detection-screening-market?utm_source=openpr

Amniocentesis Needle Market: The Amniocentesis Needle Market Report is segmented by needle length (150 mm), procedure (including amniocentesis, amnioreduction, fetal blood transfusion, amnioinfusion, and cordocentesis), end user (hospitals, specialty clinics, and ambulatory surgical centers), and geography (North America, Europe, Asia-Pacific, and more), with market forecasts presented in terms of value (USD).

Get more insights: https://www.mordorintelligence.com/industry-reports/amniocentesis-needle-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.